| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $767.1M | +15.6% |
| Cost of Revenue | $358.2M | +20.3% |
| R&D Expense | $111.9M | +14.6% |
| SG&A Expense | $73.1M | +7.3% |
| Operating Income | $152.7M | +13.7% |
| Pre-tax Income | $158.1M | +17.9% |
| Income Tax | $29.2M | +23.6% |
| Net Income | $129.0M | +16.7% |
| EPS (Basic) | $2.05 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225.5M | -14.5% |
| Accounts Receivable | $166.8M | +34.0% |
| Current Assets | $415.4M | +1.7% |
| Total Assets | $570.2M | +5.6% |
| Current Liabilities | $315.6M | +26.7% |
| Stockholders' Equity | $226.8M | -9.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $179.6M | -3.0% |
| Capital Expenditures | $6.6M | +64.0% |
| Investing Cash Flow | -$6.6M | -64.0% |
| Financing Cash Flow | -$204.5M | -69.8% |
| Free Cash Flow | $173.0M | -4.5% |
| +17.8% |
| EPS (Diluted) | $2.03 | +18.0% |